Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-55.43	27.94	62.70
Graham Fair Price	100.14	2.96	1.48
PEG	-93.88	0.03	-0.53
Price/Book	3.53	1.22	1.17
Price/Cash Flow	-49.50	20.79	41.16
Prices/Earnings	-74.11	9.75	37.66
Price/Sales	-6.23	3.07	3.27
Price/FCF	-49.50	20.79	41.16
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	47.66	0.18	0.12
Operating Margin	235.38	0.12	0.04
ROA	308.89	0.02	< 0.005
ROE	< 0.005	0.03	299.87
ROIC	< 0.005	0.02	355.85
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.05	11.61
Dividends QOQ	-0.86	-0.28	67.47
EBIT QOQ	-0.67	2.80	315.68
EPS QOQ	-0.71	3.00	323.13
FCF QOQ	-0.66	1.10	67.92
Revenue QOQ	-0.12	0.13	6.31
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	55.08	45.82	-16.81
Days Sales Outstanding (DSO)	107.57	88.02	-18.17
Inventory Turnover	1.63	1.96	20.20
Debt/Capitalization	0.31	0.30	-4.48
Quick Ratio	0.79	0.80	2.05
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	3.53	3.53	0.09
Cash	0.44	0.58	29.77
Capex	-0.04	-0.03	17.36
Free Cash Flow	0.10	0.21	105.21
Revenue	1.27	1.40	10.51
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.11	1.14	2.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.23	5.07	-61.72
Naive Interpretation	Member

06 - Financial Health · Bad

Rating